UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 10-QSB
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
For the three months ended December 31, 2002
[_] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
For the transition period from , 20 , to , 20 .
Commission File Number 0-29746
INNOVA PURE WATER, INC.
(Exact Name of Registrant as Specified in Charter)
Florida | | 59-2567034 |
(State or Other Jurisdiction of | | (I.R.S. Employer Identification Number) |
Incorporation or Organization) | | |
13130 56th Court, Suite 609, Clearwater, Florida 33760
(Address of Principal Executive Offices)
(727) 572-1000
(Registrant’s Telephone Number, Including Area Code)
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act during the past 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
X YES NO
There were 10,653,458 shares of the Registrant’s $.0001 par value common stock outstanding as of December 31, 2002.
Transitional Small Business Format (check one) Yes NO X
Innova Pure Water, Inc.
Contents
Part I – Financial Information
Item 1. Condensed Financial Statements
Item 2. Management’s Discussion & Analysis of Financial Condition and Results of Operations
Item 3. Controls and Procedures
Part II – Other Information
Item 1. Legal Proceedings
Item 2. Changes in Securities
Item 3. Defaults Upon Senior Securities
Item 4. Submission of Matters to a Vote of Security Holders
Item 5. Other Matters
Item 6. Exhibits and Reports on Form 8-K
Signatures
PART I – FINANCIAL INFORMATION
Item 1. Condensed Financial Statements
Innova Pure Water, Inc.
Condensed Financial Statements
Three and Six Months Ended
December 31, 2002 and 2001 (Unaudited)
Contents
Condensed Financial Statements: | | |
Condensed Balance Sheet for December 31, 2002 (Unaudited) | | 1 |
Condensed Statements of Operations for the Three and Six Months Ended December 31, 2002 and 2001 (Unaudited) | | 2 |
Condensed Statement of Changes in Stockholders’ Equity for the Six Months Ended December 31, 2002 (Unaudited) | | 3 |
Condensed Statements of Cash Flows for the Six Months Ended December 31, 2002 and 2001 (Unaudited) | | 4 |
Notes to Condensed Financial Statements | | 5 |
Innova Pure Water, Inc.
Condensed Balance Sheet
December 31, 2002
(Unaudited)
Assets | | | | |
Current assets: | | | | |
Cash | | $ | 7,300 | |
Accounts receivable, trade, net of allowance for doubtful accounts of $20,000 | | | 154,600 | |
Other receivables, including related party of $49,100, net of allowance for doubtful accounts of $50,000 | | | 9,700 | |
Inventories | | | 120,300 | |
Other current assets | | | 6,700 | |
| |
|
|
|
Total current assets | | | 298,600 | |
| |
|
|
|
|
Property and equipment, net | | | 56,300 | |
| |
|
|
|
|
Other assets: | | | | |
Patents, net | | | 319,800 | |
Other receivables, related party | | | 48,100 | |
Other | | | 5,700 | |
| |
|
|
|
Total other assets | | | 373,600 | |
|
| | $ | 728,500 | |
| |
|
|
|
|
Liabilities and Stockholders’ Deficit | | | | |
Current liabilities: | | | | |
Accounts payable, trade | | $ | 251,800 | |
Accrued expenses, including related party of $69,900 | | | 156,800 | |
Deferred revenue, current portion | | | 25,000 | |
Customer deposits | | | 77,500 | |
| |
|
|
|
Total current liabilities | | $ | 511,100 | |
| |
|
|
|
|
Long-term liabilities: | | | | |
Loan payable | | $ | 400,000 | |
Deferred revenue, long-term portion | | | 12,500 | |
Other liabilities, related party | | | 112,200 | |
| |
|
|
|
Total long-term liabilities | | $ | 524,700 | |
| |
|
|
|
|
Stockholders’ deficit: | | | | |
Preferred stock; $.001 par value; 2,000,000 shares authorized; 0 shares issued and outstanding | | | | |
Common stock; $.0001 par value; 50,000,000 shares authorized; 10,698,543 shares issued; and 10,653,458 shares outstanding | | | 1,000 | |
Capital in excess of par value | | | 8,306,200 | |
Accumulated deficit | | | (8,599,200 | ) |
| |
|
|
|
| | | (292,000 | ) |
Treasury stock, at cost, 45,085 shares | | | (15,300 | ) |
| |
|
|
|
Total stockholders’ deficit | | | (307,300 | ) |
| |
|
|
|
| | $ | 728,500 | |
| |
|
|
|
The accompanying notes are an integral part of the condensed financial statements.
1
Innova Pure Water, Inc.
Condensed Statements of Operations
(Unaudited)
| | Three Months Ended December 31,
| | | Six Months Ended December 31,
| |
| | 2002
| | | 2001
| | | 2002
| | | 2001
| |
Net sales | | $ | 224,200 | | | $ | 22,700 | | | $ | 249,800 | | | $ | 189,200 | |
|
Cost of sales | | | 151,400 | | | | 24,600 | | | | 161,700 | | | | 128,100 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
Gross profit | | | 72,800 | | | | (1,900 | ) | | | 88,100 | | | | 61,100 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
Operating expenses: | | | | | | | | | | | | | | | | |
Selling expenses | | | 400 | | | | 100 | | | | 1,300 | | | | 6,500 | |
General and administrative expenses | | | 183,900 | | | | 237,300 | | | | 405,000 | | | | 445,900 | |
Research and product development | | | 23,400 | | | | 26,600 | | | | 57,200 | | | | 54,400 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
| | | 207,700 | | | | 264,000 | | | | 463,500 | | | | 506,800 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
Loss from operations | | | (134,900 | ) | | | (265,900 | ) | | | (375,400 | ) | | | (445,700 | ) |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
Other (income) expenses: | | | | | | | | | | | | | | | | |
(Gain)/Loss on sale of assets | | | — | | | | — | | | | — | | | | 1,000 | |
Interest, net | | | 1,300 | | | | 100 | | | | 1,900 | | | | (300 | ) |
Royalty & other income | | | (12,900 | ) | | | (11,900 | ) | | | (42,700 | ) | | | (34,900 | ) |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
| | | (11,600 | ) | | | (11,800 | ) | | | (40,800 | ) | | | (34,200 | ) |
|
Net loss | | $ | (123,300 | ) | | $ | (254,100 | ) | | $ | (334,600 | ) | | $ | (411,500 | ) |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
Loss per common share | | $ | (.01 | ) | | $ | (.02 | ) | | $ | (.03 | ) | | $ | (.04 | ) |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
Weighted average number of Common shares outstanding | | | 10,523,023 | | | | 10,453,458 | | | | 10,488,241 | | | | 10,451,697 | |
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
The accompanying notes are an integral part of the condensed financial statements
2
Innova Pure Water, Inc.
Condensed Statement of Changes in Stockholders’ Equity (Deficit)
Six Months Ended December 31, 2002
(Unaudited)
| | Common Stock
| | Capital In Excess Of Par Value
| | Accumulated Deficit
| | | Treasury Stock
| |
| | Shares
| | Amount
| | | |
Balance, June 30, 2002 | | 10,498,543 | | $ | 1,000 | | $ | 8,282,200 | | $ | (8,264,600 | ) | | $ | (15,300 | ) |
|
Issuance of common stock for prepaid services and satisfaction of accounts payable, 200,000 shares | | 200,000 | | | | | | 24,000 | | | | | | | | |
|
Net Loss | | | | | | | | | | | (334,600 | ) | | | | |
| |
| |
|
| |
|
| |
|
|
| |
|
|
|
|
Balance, December 31, 2002 | | 10,698,543 | | $ | 1,000 | | $ | 8,306,200 | | $ | (8,599,200 | ) | | $ | (15,300 | ) |
| |
| |
|
| |
|
| |
|
|
| |
|
|
|
The accompanying notes are an integral part of the condensed financial statements.
3
Innova Pure Water, Inc.
Condensed Statements of Cash Flows
(Unaudited)
| | Six Months Ended December 31,
| |
| | 2002
| | | 2001
| |
Operating activities | | | | | | | | |
Net loss | | $ | (334,600 | ) | | $ | (411,500 | ) |
Adjustments to reconcile net loss to net cash used by operating activities: | | | | | | | | |
Depreciation and amortization | | | 73,300 | | | | 66,900 | |
Loss on disposal of equipment | | | | | | | 1,000 | |
(Decrease) increase in provision for doubtful accounts | | | (4,900 | ) | | | 4,600 | |
Stock and stock options issued for services | | | | | | | 1,700 | |
(Increase) decrease in: | | | | | | | | |
Accounts and other receivables | | | 8,200 | | | | 255,600 | |
Inventories | | | 40,300 | | | | (253,200 | ) |
Other assets | | | (500 | ) | | | 10,900 | |
Increase (decrease) in: | | | | | | | | |
Customer deposits on purchase orders | | | 77,500 | | | | | |
Deferred revenue | | | 37,500 | | | | | |
Increase in accounts payable and accrued expenses | | | 19,000 | | | | 69,200 | |
| |
|
|
| |
|
|
|
Total adjustments | | | 250,400 | | | | 156,700 | |
| |
|
|
| |
|
|
|
Net cash used by operating activities | | | (84,200 | ) | | | (254,800 | ) |
| |
|
|
| |
|
|
|
|
Investing activities | | | | | | | | |
Payments to related parties | | | | | | | (9,100 | ) |
Acquisition of equipment | | | | | | | (48,100 | ) |
Cost associated with new patents | | | (20,700 | ) | | | | |
| |
|
|
| |
|
|
|
Net cash used by investing activities | | | (20,700 | ) | | | (57,200 | ) |
|
Financing activities | | | | | | | | |
Advances from related parties | | | 69,700 | | | | 8,700 | |
Proceeds from loan | | | | | | | 300,000 | |
Payments on capital lease obligations | | | | | | | (2,300 | ) |
| |
|
|
| |
|
|
|
Net cash provided by financing activities | | | 69,700 | | | | 306,400 | |
|
Net decrease in cash | | | (35,200 | ) | | | (5,600 | ) |
|
Cash, beginning of period | | | 42,500 | | | | 47,900 | |
|
Cash, end of period | | $ | 7,300 | | | $ | 42,300 | |
| |
|
|
| |
|
|
|
|
Supplemental disclosure of cash flow information and noncash financing activities: | | | | | | | | |
Cash paid during the period for interest | | $ | 1,900 | | | $ | 800 | |
| |
|
|
| |
|
|
|
During the six months ended December 31, 2001, the Company incurred $24,900 of payables for the acquisition of patents.
During the six months ended December 31, 2002, the Company incurred $17,100 of payables for the acquisition of patents. Payables decreased 29,400 due to the return of purchased materials to the supplier. The Company issued 200,000 shares of common stock in payment of $17,800 in payables, as well as for $6,200 in prepaid legal services.
The accompanying notes are an integral part of the condensed financial statements.
4
Innova Pure Water, Inc.
Notes to Condensed Financial Statements
Six Months Ended December 31, 2002 and 2001 (Unaudited)
1. Condensed Financial Statements
In the opinion of management, all adjustments consisting only of normal recurring adjustments necessary for a fair statement of (a) the results of operations for the three and six-month periods ended December 31, 2002 and 2001, (b) the financial position at December 30, 2002, and (c) cash flows for the six-month periods ended December 30, 2002 and 2001, have been made.
The unaudited condensed financial statements and notes are presented as permitted by Form 10-QSB. Accordingly, certain information and note disclosures normally included in condensed financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted. The accompanying condensed financial statements and notes should be read in conjunction with the audited financial statements and notes of the Company for the fiscal year ended June 30, 2002. The results of operations for the six-month period ended December 31, 2002 are not necessarily indicative of those to be expected for the entire year.
2. Going Concern
The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. However, the Company has sustained substantial operating losses in recent years. The Company had negative cash flows from operations of approximately $361,000 for the fiscal year ended June 30, 2002. In addition for the six-months ended December 31, 2002, the Company has incurred an additional loss of $334,600, which increased the Company’s accumulated deficit to approximately $8,599,200. The Company also has a negative shareholders’ equity of approximately $307,300 as of December 31, 2002. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Management plans to consider raising additional capital through an equity offering and is actively seeking secured or unsecured debt financing. The Company is actively seeking strategic alliances that would improve sales of its products and has received several inquiries that could provide significant sales opportunities. The Company has negotiated a supply agreement with Camelbak Products. As a result of the Camelbak agreement, the Company received a $50,000 fee for in-line product exclusivity over the two-year term of the agreement. The Company is recognizing $6,250 in revenue each quarter from this payment with any remaining balance being classified as deferred revenue. The Company hopes to have additional sales opportunities with Nikken Global. The Company also plans to sustain or reduce current operating expense levels. No assurances can be given that management’s plan will be successful.
5
3. Contingencies
The Company is currently the plaintiff in a patent infringement lawsuit entitled Innova/Pure Water, Inc. v. Safari Water Filtration Systems, Inc. d/b/a Safari Outdoor Products, Defendant; Case No. 99-1781-Civ-T-23F filed by the Company on August 4, 1999. The case was filed with the U.S. District Court, Middle District of Florida, Tampa Division. The Company has claimed patent infringement of U.S. Patent 5,609,759 on the part of the Defendants. It is not yet possible to evaluate the likelihood of a favorable or unfavorable outcome.
A new royalty agreement for John E. Nohren, Jr., Chairman of the Board, has been proposed to the Board of Directors and is pending approval. The agreement would remain in effect until June 30, 2003. It includes the same terms as his previous agreement except that Mr. Nohren has agreed to accept 50% of his royalties in the Company’s common stock during any month that sufficient cash funds are not available to pay this compensation. A formal agreement is being finalized and will be presented to the Board of Directors for their approval once it has been completed.
The employment agreement of Rose Smith, President & CEO, has been extended by the Board of Directors until June 30, 2003 with essentially the same terms as her previous agreement except that Ms. Smith has agreed to accept 50% of her compensation in the Company’s common stock during any month that sufficient cash funds are not available to pay this compensation. Additionally, the provision that was in Ms. Smith’s previous agreement, which called for a 2% commission on sales, has been discontinued in the new employment agreement. A formal agreement is being finalized and will be presented to the Board of Directors for their approval once it has been completed.
4. Stock and Stock Options
Effective June 30, 2002, Mr. Nohren and Ms. Smith forgave $50,800 and $50,000, respectively, of accrued and unpaid compensation. A motion had been made to the Company’s Board of Directors that in consideration of this total $100,800 forgiveness of debt, as well as service and loyalty to the Company, options for the purchase of the Company’s common stock be granted to Mr. Nohren and Ms. Smith. On October 9, 2002, the Company’s Board of Directors approved the granting of these stock options at $0.12 per share, which was more than 110% of the fair market value of the shares on the date the options were granted. Mr. Nohren and Ms. Smith received 1,270,300 and 1,250,000 stock options, respectively.
During the quarter ended December 31, 2002, the Company issued 200,000 shares of common stock at $0.12 per share in payment of $24,000 in legal services that were unrelated to an equity offering or other fiduciary responsibility.
6
PART I – FINANCIAL INFORMATION
Item 2. Management’s Discussion & Analysis of Financial Condition and Results of Operation
This FILING contains forward-looking statements. The words “anticipated,” “believe,” “expect,” “plan,” “intend,” “seek,” “estimate,” “project,” “will,” “could,” “may,” and similar expressions are intended to identify forward-looking statements. These statements include, among others, information regarding future operations, future capital expenditures, and future net cash flow. Such statements reflect the Company’s current views with respect to future events and financial performance and involve risks and uncertainties, including, without limitation, general economic and business conditions, changes in foreign, political, social, and economic conditions, regulatory initiatives and compliance with governmental regulations, the ability to achieve further market penetration and additional customers, and various other matters, many of which are beyond the Company’s control. Should one or more of these risks or uncertainties occur, or should underlying assumptions prove to be incorrect, actual results may vary materially and adversely from those ANTICIPATED, believed, estimated, or otherwise indicated. Consequently, all of the forward-looking statements made in this FILING are qualified by these cautionary statements and there can be no assurance of the actual results or developments.
Innova cautions readers that in addition to important factors described elsewhere, the following important facts, among others, sometimes have affected, and in the future could affect, the Company’s actual results, and could cause the Company’s actual results during 2002 and beyond, to differ materially from those expressed in any forward-looking statements made by, or on behalf of, Innova.
7
INCOME STATEMENT DATA
| | Six Months Ended December 31,
| |
| | 2002
| | | 2001
| |
Total revenue | | $ | 249,800 | | | $ | 189,200 | |
| |
|
|
| |
|
|
|
Net loss | | $ | (334,600 | ) | | $ | (411,500 | ) |
| |
|
|
| |
|
|
|
Loss per common share – basic | | $ | (.03 | ) | | $ | (.04 | ) |
| |
|
|
| |
|
|
|
Shares used in per share computation | | | 10,488,241 | | | | 10,451,697 | |
| |
|
|
| |
|
|
|
BALANCE SHEET DATA
| | December 31, 2002
| |
Total assets | | $ | 728,500 | |
| |
|
|
|
Working capital | | $ | (212,500 | ) |
| |
|
|
|
Long-term debt | | $ | 524,700 | |
| |
|
|
|
Stockholders’ deficit | | $ | (307,300 | ) |
| |
|
|
|
RESULTS OF OPERATIONS
Net Sales
Net sales for the three-month period ended December 31, 2002 were $224,200, an increase of 888 percent from the $22,700 of net sales for the comparable period in 2001. This increase is attributable to the shipment of initial sales orders to new customers Camelbak and Nikken Global during the quarter while sales to a major customer, Avon Products, had stopped during the quarter ended December 31, 2001.
Net sales for the six-month period ended December 31, 2002 were $249,800, an increase of 32 percent from the $189,200 of net sales for the comparable period in 2001. This increase is attributable to the increase in sales to new customers Camelbak and Nikken Global during the quarter while sales to Avon Products had stopped during the quarter ended December 31, 2001. Avon Products has not placed a purchase order of any significant dollar amount with the Company since the quarter ended December 31, 2001.
In past years, the Company has depended on its strategic alliance trading partners to generate the vast majority of its sales in any fiscal year. The loss of any one of these trading partners can and has had a material impact on the Company’s sales and profitability. The Company currently has a trading partner relationship with Sawyer Products and hopes to further develop its business relationships with new customers Camelbak and Nikken Global.
The Company has made shipments on initial purchase orders placed by these two new customers, Camelbak and Nikken Global. Innova had previously received purchase orders from these two customers totaling $291,000. These were comprised of an order from Camelbak Products for $103,000 and an order from Nikken Global for $188,000. The Company had received customer deposits on these two purchase orders totaling $145,900. The Company recognized $198,700 in total sales revenue from shipments to Camelbak and Nikken Global during the quarter ended December 31, 2002.
For the six-month period ended December 31, 2002, the $104,200 in sales to Camelbak and $94,500 in sales to Nikken Global represented 42% and 38%, respectively, of total sales made. On December 31, 2002, there was a remaining sales backlog of $92,300 on the initial Nikken Global purchase order. The Company has negotiated a supply agreement with Camelbak Products.
While the Company has entered into several strategic alliances in previous years with companies such as Rubbermaid and U.S. Filter (Culligan), none of these alliances have resulted in the long-term trading partner relationships that would assist the Company in achieving its goal of becoming profitable. There are no assurances that any current strategic alliances will result in the Company becoming profitable.
8
Cost of Sales
For the three months ended December 31, 2002, the cost of sales increased to $151,400 from the $24,600 of costs for the six months ended December 31, 2001. This increase is mainly due to the increase in sales.
For the six months ended December 31, 2002, the cost of sales increased to $161,700 from the $128,100 of costs for the six months ended December 31, 2001. This increase is mainly due to the increase in sales.
Gross profit margin was 32 percentage points for the three months ended December 31, 2002, compared to a negative gross profit of $1,900 for the three-months ended December 31, 2001. This increase is principally attributable to the higher sales volume and increased efficiencies in the manufacturing process.
Gross profit margin increased 3 percentage points for the six months ended December 31, 2002, to a gross profit margin of 35 percent from an overall gross profit margin of 32 percent for the six months ended December 31, 2001. This increase is principally due to increased efficiencies in the manufacturing process.
Operating Expense
Operating expenses for the three months ended December 31, 2002 were $207,700 as compared to $264,000 for the similar period last year. The 21 percent decrease in operating expenses is principally attributable to the decrease in general and administrative expenditures.
Operating expenses for the six months ended December 31, 2002 were $463,500 as compared to $506,800 for the similar period last year. The 9 percent decrease in operating expenses is principally attributable to the decrease in general and administrative expenditures.
Other Income
For the three months ended December 31, 2002, net interest expense amounted to $1,300 as compared to net interest expense of $100 for the three months ended December 31, 2001. This increase is due to the increase in accrued interest payable to vendors on unpaid invoices for goods and services received.
For the six months ended December 31, 2002, net interest expense amounted to $1,900 as compared to net interest income of $300 for the six months ended December 31, 2001. This change is principally due to the increase in accrued interest payable to vendors on unpaid invoices for goods and services received.
Royalty and other income for the three and six months ended December 31, 2002 of $12,900 and $42,700, respectively, was due to royalties payments from Brita and the realization of revenue from an exclusivity fee paid to the Company by Camelbak Products as a result of a supply agreement reached between the two parties. . The Company received a total fee of $50,000 for in-line product exclusivity over the current two-year term of the Camelbak agreement. Approximately $6,300 of this fee will be recognized as revenue during each quarter of the term of this agreement with any remaining balance classified as deferred revenue. The Company had realized $12,500 in revenue from the Camelbak agreement for the six months ended December 31, 2002.
Royalty and other income for the three and six months ended December 31, 2001 of $11,900 and $34,900, respectively, was principally due to royalties payments from Brita.
Income Taxes
Due to the Company’s history of operating losses, management has established a valuation allowance in the full amount of the deferred tax assets arising from these losses because management believes it is more likely than not that the Company will not generate sufficient taxable income within the appropriate period to offset these operating loss carryforwards.
Net Loss
Net loss for the three months ended December 31, 2002 amounted to $123,300 as compared to net loss of $254,100 for the six months ended December 31, 2001. This decrease in net loss is principally attributable to the increase in sales and the decrease in general and administrative expenditures.
Net loss for the six months ended December 31, 2002 amounted to $334,600 as compared to net loss of $411,500 for the six months ended December 31, 2001. This decrease in net loss is principally attributable to the increase in sales and the decrease in general and administrative expenditures.
Loss Per Share
For the three months ended December 31, 2002, basic loss per share amounted to $(.01). For the comparable period in 2001, basic loss per share amounted to $(.02).
For the six months ended December 31, 2002, basic loss per share amounted to $(.03). For the comparable period in 2001, basic loss per share amounted to $(.04).
9
LIQUIDITY AND CAPITAL RESOURCES
Operating Activities
For the six months ended December 31, 2002, net cash used by operating activities amounted to approximately $84,200, compared to the net cash used by operating activities of approximately $254,800 for the comparable period in 2001. This decrease in cash used is primarily a result of customer deposits received on purchase orders and an exclusivity fee received as a result of the supply agreement with Camelbak Products. This were partially offset by a decrease in collections from accounts receivable due to the timing of the majority of the sales for the quarter ended December 31, 2002, the goods shipped during December 2002, which was partially offset by decreased expenditures on inventory replenishment.
Investment Activities
The Company’s investment activities include equipment purchases and patent acquisitions.
Net cash used by investing activities for the six months ended December 31, 2002 was approximately $20,700, as compared to net cash used by investing activities of approximately $57,200 for the comparable period in 2001. This decrease in cash expended for investing activities is due primarily to decreased expenditures for equipment partially offset by cash expenditures for new patent acquisitions.
Financing Activities
The Company’s financing activities include advances from related parties and payments on capital lease obligations.
Net cash of approximately $69,700 was provided by financing activities for the six months ended December 31, 2002, as compared to net cash provided by financing activities of approximately $306,400 for the six months ended December 31, 2001. This decrease resulted from the receipt of a $300,000 loan during the six months ended December 31, 2001, partially offset by increased advances from related parties during the quarter ended December 31, 2002.
CAPITAL RESOURCES
At December 31, 2002, the Company does not have any material commitments for capital expenditures other than for those expenditures incurred in the ordinary course of business.
Going Concern Assumptions
The Company’s independent certified public accountants have stated that there is substantial doubt about the Company’s ability to continue as a going concern. Management is actively seeking additional capital through secured, or unsecured, debt financing. It may also consider raising additional capital through an equity offering. The Company is actively seeking strategic alliances that would improve sales of its products. The Company has received several inquiries that could provide significant sales opportunities, however, there is no guarantee that these will develop into trading partner relationships. The availability of additional capital resources will depend on prevailing market conditions, interest rates, and the existing financial position and results of operations of the Company.
10
Other
Effective June 30, 2002, John E. Nohren, Jr., Chairman of the Board, and Rose Smith, President & CEO, forgave $50,800 and $50,000, respectively, of accrued and unpaid compensation. A motion had been made to the Company’s Board of Directors that in consideration of this total $100,800 forgiveness of debt, as well as service and loyalty to the Company, that options for the purchase of the Company’s common stock be granted to Mr. Nohren and Ms. Smith. On October 9, 2002, the Company’s Board of Directors approved the granting of these stock options at $0.12 per share, which was more than 110% of the fair market value of the shares on the date the options were granted. Mr. Nohren and Ms. Smith received 1,270,300 and 1,250,000 stock options, respectively.
Item 3. Controls and Procedures
(a) | | Evaluation of disclosure controls and procedures. Based on their evaluation as of a date within 90 days of the filing date of this Quarterly Report on Form 10-QSB, the Registrant’s principal executive officer and principal financial officer have concluded that the Registrant’s disclosure controls and procedures, as defined in Rules 13a-14(c) under the Securities Exchange Act of 1934 (the “Exchange Act”), are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission rules and forms. |
(b) | | Changes in internal controls. There were no significant changes in the Registrant’s internal controls or other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
The Company is currently the plaintiff in a patent infringement lawsuit entitled Innova/Pure Water, Inc. v. Safari Water Filtration Systems, Inc. d/b/a Safari Outdoor Products, Defendant; Case No. 99-1781-Civ-T-23F filed by the Company on August 4, 1999. The case was filed with the U.S. District Court, Middle District of Florida, Tampa Division. The Company has claimed patent infringement of U.S. Patent 5,609,759 on the part of the Defendants. It is not yet possible to evaluate the likelihood of a favorable or unfavorable outcome.
Item 2. Changes in Securities
During the six-month period ended December 31, 2002, there was no modification of any instruments defining the rights of holders of the Company’s common stock and no limitation or qualification of the rights evidenced by the Company’s common stock as a result of the issuance of any other class of securities or the modification thereof.
11
Item 3. Defaults Upon Senior Securities
During the six-month period ended December 31, 2002, the Company was not in default on any of its indebtedness.
Item 4. Submission of Matters to a Vote of Security Holders
During the six-month period ended December 31, 2002, the Company did not submit any matters to a vote of its security holders.
Item 5. Other Matters
The Company does not have any other material information to report with respect to the six-month period ended December 31, 2002.
Item 6. Exhibits and Reports on Form 8-K
(a) | | Exhibits included herewith are: |
None
(b) | | Reports on Form 8-K – None |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereto duly authorized:
| | INNOVA PURE WATER, INC. |
|
Dated: | | February 14, 2003 | | By: | | /s/ ROSE SMITH |
| |
| | | |
|
| | | | | | Rose C. Smith President, Chief Executive Officer Director |
|
Dated: | | February 14, 2003 | | By: | | /s/ JOHN E. NOHREN, JR. |
| |
| | | |
|
| | | | | | John E. Nohren, Jr. Chairman of the Board of Directors Chief Financial Officer |
12
Certifications
I, Rose Smith, certify that:
1. | | I have reviewed this quarterly report on Form 10-QSB of Innova Pure Water, Inc.; |
2. | | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. | | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. | | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have: |
| a) | | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
| b) | | evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and |
| c) | | presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. | | The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a) | | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and |
| b) | | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and |
6. | | The registrant’s other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: February 14, 2003
/s/ ROSE SMITH
|
Rose Smith President & CEO |
| | |
13
I, John E. Nohren, Jr., certify that:
1. | | I have reviewed this quarterly report on Form 10-QSB of Innova Pure Water, Inc.; |
2. | | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. | | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. | | The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have: |
| a) | | designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
| b) | | evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and |
| c) | | presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; |
5. | | The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a) | | all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and |
| b) | | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and |
6. | | The registrant’s other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
Date: February 14, 2003
/s/ JOHN E. NOHREN, JR.
|
John E. Nohren, Jr. |
Chairman & CFO |
14